Regencell Bioscience Holdings Limited (RGC)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Yat-Gai Au
|
Founder, Chairman & CEO | -- | -- | 1973 |
|
Ms. Michelle Chan
|
Financial Controller, CFO & Principal Financial Officer | -- | -- | -- |
|
Mr. Wai Hong Chung
|
COO, Chief Strategy Officer & Director | 245.64k | -- | 1978 |
|
Ms. Antonia Assang
|
Senior Vice President of Project Management | -- | -- | -- |
|
Mr. Yat-Pui Au
|
Chief Business Officer | -- | -- | 1975 |
Regencell Bioscience Holdings Limited
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 10
Description
Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Corporate Governance
Upcoming Events
October 28, 2026 at 8:00 PM UTC
Regencell Bioscience Holdings Limited Earnings Date
